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has correlated a reduced level of MAD2 protein expression Nasopharyngeal carcinoma (NPC) occurs with a high incidwith defective mitotic checkpoint control in breast cancer cell ence in many countries in south-eastern Asia. Chromosomal lines (13) . abnormalities have been commonly found in NPC, but We have been studying the genetic and phenotypic alterations the underlying mechanism is not well understood. We associated with NPC as well as the roles of these alterations determined mitotic indices, the staining pattern of nuclear in tumour development and progression (14) (15) (16) . To investigate DNA and cell cycle profiles of NPC cells in response to whether mitotic checkpoint plays a role in the chromosomal treatment with microtubule-disrupting agents, and found instability commonly observed in NPC, we investigated the that the mitotic checkpoint was defective in two out of five competence of the mitotic checkpoint and the possible cause (40%) of the tested NPC cell lines. We also observed that of checkpoint defects in NPC cells. Using five NPC cell lines, an aberrantly reduced expression of MAD2, one of the key we studied the mitotic index and cell cycle distribution in components of mitotic checkpoint, correlated with the loss response to the microtubule-disrupting agents nocodazole and of checkpoint control. Our findings suggest that a defective colcemid, and then investigated the expression of three key mitotic checkpoint characterized by reduced expression of mitotic checkpoint proteins MAD1, MAD2 and p55 CDC in MAD2 contributes to chromosomal instability in NPC.
these cell lines.
To evaluate the checkpoint function in response to microtubule disruption in NPC cells, five NPC cell lines CNE1, CNE2, CNE3, SUNE1 and 915 (16, 17) and HeLa cells Nasopharyngeal carcinoma (NPC), although relatively rare were treated with nocodazole and colcemid, two microtubuleamong Caucasians, is common in Hong Kong, southern China disrupting agents that block spindle assembly through different and many other parts of south-eastern Asia (1) . Although this mechanisms. Firstly, mitotic indices were determined to assess disease is a significant cause of morbidity and mortality the percentage of cells arrested at mitosis at different time worldwide, the molecular basis of tumorigenesis in NPC is points up to 48 h after drug treatment. HeLa cells previously poorly understood. In contrast to many other human tumours, demonstrated to be checkpoint-competent (11,13) were used mutations of the p53 and Rb genes are not common events in as positive control. We noted that HeLa cells responded to NPC (2, 3) . However, chromosomal abnormalities, including drug treatment by accumulating mitotic cells, with a peak at numerical changes, chromosomal deletions and amplifications, 18 h ( Figure 1 ). Three NPC cell lines CNE1, 915 and SUNE1 have been frequently reported (4) (5) (6) (7) . It is generally accepted (solid lines) behaved in a similar manner to HeLa, indicating that nearly all solid tumours are genetically unstable. In most an intact checkpoint function. By contrast, in CNE2 and CNE3 cases, chromosomal instability results in frequent gain and cells (dotted lines), there was either a complete lack of mitotic loss of chromosomes in human cancer cells. In some colon arrest or lack of clear peak in mitotic index after treatment with cancers, and in other cases, microsatellite instability reflects nocodazole and colcemid, suggesting a defect in checkpoint an elevated nucleotide mutation rate. In yeast, disruption of response. One simple explanation for the lack of mitotic arrest spindle checkpoint genes can lead to chromosomal instability is that CNE2 and CNE3 cells could have been able to inactivate since checkpoint-defective cells complete mitosis even in the or expel nocodazole and colcemid. To rule out this possibility, presence of abnormal chromosomes (8) . To date, however, we stained HeLa and CNE3 cells for α-tubulin by immunofluolittle is known about the underlying mechanism of the mitotic rescence in the presence and in the absence of nocodazole checkpoint defects in human cancers. Since the identification ( Figure 2A ). In untreated cells, α-tubulin was visualized in of MAD (mitotic arrest deficient) and Bub (budding uninhibited microtubules arranged in long fibres, which fill the entire by benzimidazole) gene families (9), attempts have been made cytoplasm (left panels). In cells treated with nocodazole, the to find mutations of mitotic checkpoint genes in human microtubule arrays disappeared and α-tubulin was found in cancers with chromosomal instability. Only a small fraction the cell periphery (right panels). These results suggest that in of colorectal cancers have been observed to contain somatic both cell lines, treatment with nocodazole results in the mutations of the Bub1 gene (10). Consistent with this, somatic disruption of microtubules. Next we compared the staining mutations of the MAD1 and MAD2 genes and of the CDC patterns of nuclear DNA in treated and untreated cells (Figure gene encoding p55 have also been found at a low frequency 2B). This analysis revealed a significant difference between the two groups of cells. In the HeLa, CNE1, 915 and SUNE1
Abbreviation: NPC, nasopharyngeal carcinoma.
shown), which generally agrees with the results from colon cancer cell lines (11). We next determined the levels of expression of the mitotic checkpoint proteins MAD1, MAD2 and p55 CDC in the five NPC cell lines. MAD1 and MAD2 are thought to be centrally involved in sensing chromosome positions and spindle attachment and transducing the signal to the cell cycle machinery (13, (18) (19) (20) . There is evidence that MAD2 may be involved in signalling abnormalities in kinetochore-microtubule attachments (13) . In addition, MAD2 forms a complex with MAD1 and seems to transmit its signal by associating with another protein, p55 CDC (equivalent to yeast CDC20), which then activates the cyclin destruction machinery through the anaphase promoting complex (APC) (21, 22) . We have obtained highly specific antibodies against human MAD1, MAD2 and p55 CDC sion of MAD2, both expressing 60-70% less MAD2 at steady state than in HeLa cells. The other two checkpoint proteins, MAD1 and p55 CDC , were also differentially expressed in cells, which showed a peak in mitotic index in response to drug treatment, there was an accumulation of cells with CNE2 and CNE3 cells. In contrast, expression of the tumour suppressor proteins p53, Rb and p21 WAF1 was the same in all condensed chromosomes, a characteristic of mitotic block. In the CNE2 and CNE3 cell lines, which showed much lower five cell lines (Figure 3) . Collectively, our data suggest that aberrantly reduced expression of mitotic checkpoint protein mitotic index after treatment, DNA condensation did not occur. Cell cycle analysis was then performed to verify the distribution MAD2 accompanies the checkpoint dysfunction in NPC cell lines CNE2 and CNE3. of cells in different phases with or without treatment with nocodazole (Table I) ility and oncogenesis. The human MAD1 was initially identified as a binding partner and a cellular target of human T-cell However, the proportion of cells with Ͼ4N DNA content was higher, indicating that the mitotic checkpoint has been leukemia virus type I oncoprotein Tax (18) . Mutations of BUB1 and MAD1 have also been found in a small proportion overridden. Results from the above assays consistently point to a defective mitotic checkpoint in CNE2 and CNE3 cells, of colon, lung and breast cancers (10-12,24). However, mechanisms of aneuploidy and chromosomal deletion or amplificai.e. in two of the five NPC cell lines tested (40%). This is comparable to data published on human lung cancers, in which tion were not understood. Our finding that a mitotic checkpoint was affected provides an explanation for the chromosomal four out of nine (44%) cell lines had a defective mitiotic checkpoint (11).
defects seen in NPC. Previous cytogenetic analysis has documented significant We provide the first evidence that the mitotic checkpoint is frequently defective in NPC cells. Our data indicate that chromosomal abnormalities in CNE2 cells (25) . It is noteworthy that this NPC cell line has structurally abnormal chromosomes defects in mitotic checkpoint could be one cause of the chromosomal instability commonly seen in NPC. Further distinct from other NPC lines including CNE1. Two unique giant markers for CNE2 have been defined by chromosome characterization of the nature and molecular mechanisms of these checkpoint defects should provide important insights banding and there are dramatic differences between CNE2 and CNE1 (25) . These data suggest that checkpoint-defective CNE2 into the oncogenesis of NPC. As a first step towards this end, we searched for mutations in key components of the mitotic may have more severe chromosomal abnormalities than the other checkpoint-competent NPC lines. This further supports checkpoint such as the MAD1, MAD2 and p55 CDC genes. No genetic alterations were found using this approach (data not the concept that mitotic checkpoint dysfunction leads to chromosomal instability. In this regard, the five NPC cell lines ( Figure 3) ; this aberrantly reduced expression of MAD2 accompanied a defective mitotic checkpoint response to treatmerit a more extensive and systematic cytogenetic analysis.
Our evidence is also a first demonstration of the association ment with nocodazole and colcemid (Figures 1 and 2 ; Table  I ). In contrast, the checkpoint-competent cell lines showed between the steady-state amounts of MAD2 protein, which is thought to be one of the key proteins in regulating mitotic comparable levels of this protein. However, the relative amount of p55CDC did not seem to affect the mitotic control as the checkpoint (22), and the mitotic checkpoint competence. Thus, CNE2 and CNE3 cells showed lowest levels of MAD2 protein was barely detectable in HeLa cells but a normal point. However, elucidation of the exact roles of MAD1, have demonstrated an association between reduced expression of MAD2 protein and loss of mitotic checkpoint in these cells.
Cells (10 6 ) were treated with nocodazole (50 nM) for 18 h and fixed. Before testing, the cells were treated with RNase (10 µg/ml) and propidium
Our findings provide a novel mechanism to explain, at least iodide (50 µg/ml) for 30 min at 37°C and analysed on an EPICS profile in part, the chromosomal instability commonly seen in NPC. cancer drugs such as taxol, the difference in the mitotic checkpoint protein expression may be informative in determining the difference between microsatellite instability and chromosomal instability in human tumours and facilitating the successful use of chemotherapy.
